Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Chronic thromboembolic pulmonary hypertension.
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Chronic thromboembolic pulmonary hypertension.
复制标题
DOI：
10.4103/1817-1737.134037
复制
发表时间：
2014-07
影响因子：
2.3
通讯作者：
Idrees MM
中科院分区：
文献类型：
--
作者：
Mayer E;Idrees MM
慢性血栓栓塞性肺动脉高压(CTEPH)在WHO对肺动脉高压的分类中被归类为IV组。这种疾病需要非常低的怀疑指数来识别，需要利用临床、放射学和血流动力学工具的特殊诊断方法。由于CTEPH是潜在的可治愈的，应尽一切努力达到准确的诊断，并随后评估可操作性。虽然肺内膜剥脱术(PEA)是迄今为止唯一的治疗手段，但最近关于内科和介入治疗的最新进展在不能手术的患者中取得了重大进展。在这篇综述中，我们对诊断算法、手术操作标准、PEA和内科治疗进行了详细的讨论。
Chronic thromboembolic pulmonary hypertension (CTEPH) is categorized as group IV in the WHO classification for pulmonary hypertension. The disease requires a very low index of suspicion for identification and needs a special diagnostic approach utilizing clinical, radiological, and hemodynamic tools. As CTEPH is potentially curable, all efforts should be consumed to reach the accurate diagnosis and subsequently evaluated for operability. Although pulmonary endarterectomy (PEA) is the only curative tool so far, recent updates concerning medical and interventional therapy have made significant advances in inoperable patients. In this review, we provide a detailed discussion on diagnostic algorithm, surgical operability criteria, PEA, and the medical therapy.
登录
查看更多内容
DOI：
10.1161/circinterventions.112.971390
发表时间：
2012-12-01
影响因子：
5.6
作者：
Kataoka, Masaharu;Inami, Takumi;Satoh, Toru
通讯作者：
Satoh, Toru
DOI：
10.1161/circinterventions.112.971077
发表时间：
2012-12-01
影响因子：
5.6
作者：
Mizoguchi, Hiroki;Ogawa, Aiko;Matsubara, Hiromi
通讯作者：
Matsubara, Hiromi
影响因子：
37.8
作者：
Pepke-Zaba, Joanna;Delcroix, Marion;Simonneau, Gerald
通讯作者：
Simonneau, Gerald
影响因子：
37.8
作者：
Jensen, Kurt W.;Kerr, Kim M.;Auger, William R.
通讯作者：
Auger, William R.
影响因子：
2.3
作者：
Idrees, Majdy M;Batubara, Enas;Kashour, Tarek
通讯作者：
Kashour, Tarek